These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25116888)

  • 21. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
    van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
    BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current asthma management.
    Higgins BG
    Practitioner; 1999 May; 243(1598):376-80, 384. PubMed ID: 10534887
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled BDP/formoterol extra-fine combination. Evidence and future perspectives.
    Papi A
    Pneumologie; 2009 Dec; 63 Suppl 2():S102-6. PubMed ID: 20013538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe asthma: advances in current management and future therapy.
    Barnes PJ
    J Allergy Clin Immunol; 2012 Jan; 129(1):48-59. PubMed ID: 22196524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
    Rodrigo GJ; Castro-Rodríguez JA
    Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical considerations in the use of inhaled corticosteroids for asthma.
    Williams DM
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):38S-48S. PubMed ID: 11253867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
    Chantaphakul H; Ruxrungtham K
    Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 33. Asthma.
    Cates C; FitzGerald JM
    Clin Evid; 2002 Dec; (8):1506-29. PubMed ID: 12603951
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principal findings of systematic reviews of acute asthma treatment in childhood.
    Castro-Rodriguez JA; J Rodrigo G; E Rodríguez-Martínez C
    J Asthma; 2015; 52(10):1038-45. PubMed ID: 26303207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of anticholinergics in asthma management: recent evidence and future needs.
    Rogers L; Hanania NA
    Curr Opin Pulm Med; 2015 Jan; 21(1):103-8. PubMed ID: 25415409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
    Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
    J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.